Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Fosfomycin Disodium
2. 26016-99-9
3. Phosphonemycin
4. Fosfomycin Disodium Salt
5. Phosphomycin Disodium Salt
6. Veramina
7. Disodium Phosphonomycin
8. Disodium (1r,2s)-(1,2-epoxypropyl)phosphonate
9. Fosfomycin Sodium [jan]
10. Disodium Fosfomycin
11. Priomicina
12. Fosfomycin Sodium Salt
13. 97mmo19fno
14. Fosfocina Disodium Salt
15. Phosphonomycin Disodium Salt
16. Sodium Fosfomycin
17. Phosphonomycin Sodium
18. Phosphonic Acid, [(2r,3s)-3-methyloxiranyl]-, Disodium Salt
19. Disodium [(2r,3s)-3-methyloxiran-2-yl]phosphonate
20. Fom-na
21. Mk 955
22. Fosfocin
23. Forocyle S
24. Fosmicin S
25. Nsc-136017
26. Einecs 247-409-2
27. Unii-97mmo19fno
28. Nsc 136017
29. Levo-phosphonomycin Disodium Salt
30. (?)-fosfomycin
31. Fosmicin S (tn)
32. Phosphonemycin Disodium
33. (2r-cis)-(3-methyloxiranyl)phosphonic Acid Disodium Salt
34. (1r,2s)(-)-(1,2-epoxypropyl)phosphonic Acid Disodium Salt
35. Phosphonic Acid, (3-methyloxiranyl)-, Disodium Salt, (2r-cis)-
36. Fosfomycin Sodium (jp17)
37. Schembl9634056
38. Chembl1256140
39. Fosfomycin Sodium [mart.]
40. Dtxsid401017220
41. Fosfomycin Sodium [who-dd]
42. Mfcd00056853
43. Phosphonic Acid, (1,2-epoxypropyl)-, Disodium Salt (1r,2s) (-)-
44. Akos015963278
45. Ccg-266439
46. Fosfomycin Sodium [ep Impurity]
47. Fosfomycin Sodium [ep Monograph]
48. 25162-71-4
49. As-11021
50. As-13713
51. F0889
52. Disodium (1r,2s)-1,2-epoxypropylphosphonate
53. D02188
54. Sodium ((2r,3s)-3-methyloxiran-2-yl)phosphonate
55. Fosfomycin Sodium, Vetranal(tm), Analytical Standard
56. Q27272022
57. (1r,2s)-1,2-epoxypropylphosphonic Acid Disodium Salt
58. Disodium (2r,3s)-3-methyloxiran-2-ylphosphonate
59. Phosphomycin Disodium Salt, Antibacterial Mura Inhibitor
60. Z1583387379
61. Phosphonic Acid,(3-methyloxiranyl)-,disodium Salt,cis-(+-)-
62. Disodium;[(2r,3s)-3-methyloxiran-2-yl]-dioxido-oxo-lambda5-phosphane
Molecular Weight | 182.02 g/mol |
---|---|
Molecular Formula | C3H5Na2O4P |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 0 |
Exact Mass | 181.97208420 g/mol |
Monoisotopic Mass | 181.97208420 g/mol |
Topological Polar Surface Area | 75.7 Ų |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 127 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.
Regulatory Info : Dossier Availability: Q2 2025
Registration Country : Poland
Brand Name :
Dosage Form : Powder for Solution for Infusion
Dosage Strength : 40MG/ML
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Availability: Q2 2025
Registration Country : Poland
Regulatory Info :
Registration Country : China
Brand Name :
Dosage Form : Powder for Injection
Dosage Strength : 1g
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : China
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?